Icotrokinra
Overview
Icotrokinra is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL6068124).
API suppliers (1)
Suppliers of Icotrokinra evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
- SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTDChina1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Icotrokinra expires 19 Nov 2041 and exclusivity 17 Mar 2031. Generic API sourcing typically opens up once these lapse.
Do you supply Icotrokinra? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.